News
New Research Boosts Future Whooping Cough Vaccines
Whooping cough, or pertussis, was once a leading cause of death for children in the U.S. and worldwide before the introduction of vaccines in the...
Research Identifies Key Antibodies for Development of Broadly Protective Norovirus Vaccine
Discovery brings us one step closer to vaccine and treatment for prevalent virus.
New inroads on a quiet and deadly cancer
Pancreatic cancer hides deep within the body. A new translational science partnership is tracking cancer’s footprint through metabolism.
Turbocharging Protein Engineering with AI
Biotech advances from UT’s new Deep Proteins group are changing the game with help from artificial intelligence.
Newly Discovered Antimicrobial Could Prevent or Treat Cholera
Natural antimicrobials called microcins are produced by bacteria in the gut and show promise in fighting infection.
AI Opens Door to Safe, Effective New Antibiotics to Combat Resistant Bacteria
Protein large language models identify ways to make antibiotics better at targeting dangerous bacteria, without being toxic to humans.
Department of Molecular Biosciences
McLellan Named Recipient of the 2024 IVI-SK Bioscience Park MahnHoon Award
The International Vaccine Institutes Bioscience Park MahnHoon Award recognizes his role in the development of several vaccines.
McLellan Named Recipient of Award for Achievement in Public Health
Jason McLellan has been named the recipient of a Research!America Advocacy Award for his work on COIVD-19 vaccines
Cancer Drug Restores Immune System’s Ability to Fight Tumors
Drug candidate developed by Everett Stone and his team is effective in mice with cancers of skin, bladder, blood and colon.
FDA-Approved RSV Vaccine Enabled by Work of UT Molecular Biologist
Every year, millions of people become sickened by RSV, and more than 100,000 die. New vaccines with a connection to UT Austin may help turn those numbers around.
